!– Request: gene-variant-databases –> <!– Matched Rewrite Rule: (.?.+?)(?:/([0-9]+))?/?$ –> <!– Matched Rewrite Query: pagename=gene-variant-databases&page= –> <!– Loaded Template: page.php –>
Accelerate test turnaround and enable confident decisions with expert-curated gene- and variant-level insights for NGS data interpretation and reporting
Across all genomic profiling applications, from research to molecular testing and pharmaceutical development, the ability to identify and interpret potentially actionable genetic alterations is becoming increasingly difficult. As NGS tests increase in size, more biomarkers are uncovered, and demand for routine testing soars, labs need the most up-to-date, biological and clinical information directly in their informatics pipeline to identify and classify variants rapidly and confidently.
Transform unstructured data into actionable insight. By aggregating, manually curating, and modeling scientific literature and professional guidelines with semantic consistency, QIAGEN Digital Insight’s portfolio of gene- and variant-level databases captures biological, phenotypic, therapeutic, and outcomes information that enable variant- and disease-specific classifications for every alteration in every disease for every patient case.
Drive successful precision medicine programs with real-world data that helps you find and validate the right targets faster, identify appropriate patient cohorts, and enhance your companion diagnostic (CDx) design.
Reduce test turnaround time, improve variant classification, and standardize decision-making with expert-curated gene- and variant-level insights for NGS data interpretation and reporting for germline and somatic applications.
Accelerate and enable your research by leveraging genomic- and clinically-annotated oncology data to help you conduct in-depth searches on variant functionality and confidently determine a variant’s biological significance.
High-touch, expert curation methods are essential to provide consistent and accurate biological and clinical variant interpretation. In this white paper, learn about the different methods of data curation for clinical NGS testing, best practices for incorporating data into clinical reports, and the value of combining automation and human judgment in decision-making.
Experience the value of QIAGEN’s gene and variant databases directly in your lab. Requst a consultation by filling out the form below, and our experts will set up a free trial of the database of your choice.
Clinical decision support software for NGS inherited disease, hereditary cancer, and oncology applications
Clinical decision support software integrated with professional interpretation services for NGS oncology applications
Out-of-the-box and custom NGS panels enabling digital DNA and RNA sequencing to confidently detect low-frequency variants